What is the Ownership and Shareholding Structure of Eiko Lifesciences?
In 2022, Eiko Lifesciences had a promoter holding of 10.59% and a public holding of 89.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.











Company Details
+91-XXXXXXXXXX